A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer
Clinical trial NCT05509790 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05509790
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-09
- Primary completion
- 2024-02-18
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.